Patients receiving insulin showed a median −1.1 kPa and −21.0 dB/m reduction from baseline fibrosis and steatosis levels, respectively, while placebo-treated patients showed median increases of 0.3 kPa and 13.0 dB/m, respectively. The gene discussed is INS; the disease is fibrosis.